T cells are still the most accurate urinary biomarker for lupus nephritis, reported Katharina Kopetschke and her coauthors.
In a study of 123 lupus p... More »
The antimalarial drug chloroquine (Aralen) reduced the frequency of metabolic syndrome in young adult premenopausal systemic lupus erythematosus (SLE)... More »
Larger doses of the corticosteroid prednisone increased the risk of developing organ damage in patients with systemic lupus erythematosus (SLE), accor... More »
There are important differences in how mycophenolate mofetil and cyclophosphamide treat patients with systemic lupus erythematosus, according to Dr. T... More »
Black and Hispanic patients with end-stage renal disease caused by lupus nephritis were 27% less likely to receive pre-ESRD care than were their white... More »
SNOWMASS, COLO. – A full decade after a large multicenter study identified non-Hodgkin’s lymphoma as the major cancer risk associated with SLE, it... More »
Periostin stains correlated with chronicity index scores and renal functions in lupus nephritis patients and may be an effective biomarker, according ... More »
Systematic lupus erythematosus is not a risk factor for poor outcomes after total hip or knee arthroplasty, according to Dr. Ummara H. Shah and her as... More »
Measuring proteinuria 12 months into a clinical trial is the best way to predict long-term renal outcomes in lupus nephritis patients, according to re... More »
The findings of a new study challenge the importance of anti–double stranded DNA antibodies as a diagnostic hallmark for lupus.
The assessment of different anti–double stranded DNA (dsDNA) antibody...